WuXi Biologics, a Chinese biopharmaceuticals company, announced on Monday the sale of its WuXi Vaccines facility in Ireland ...

Merck, a leading science and technology company, today launched a beta version of M-Trust™, a secure cyber-physical trust ...

A wall showing a Merck & Co. logo in Kenilworth ... which would allow the company to launch the antibody medicine ahead of the typical RSV fall-to-winter season. If approved, clesrovimab would ...

“I am thrilled to join such an innovative company at the forefront of gene editing,” said Briggs Morrison, M.D. “I look forward to collaborating with the Board and the management team to drive CRISPR ...

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...

The rising prevalence of diabetes is anticipated to drive the expansion of the semaglutide market in the coming years.

Shares of Merck & Co. Inc. MRK slipped 0.03% to $99.14 Friday, on what proved to be an all-around great trading session for ...